Literature DB >> 25056402

Frequent involvement of central nervous system in primary Sjögren syndrome.

Isabel Moreira1, Filipa Teixeira, Ana Martins Silva, Carlos Vasconcelos, Fátima Farinha, Ernestina Santos.   

Abstract

Primary Sjögren syndrome (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and tear glands, and autoantibody secretion, in the absence of other systemic autoimmune disorder. Among autoimmune diseases, it is a relatively common disease, but the burden of central nervous system (CNS) involvement is controversial. This retrospective study evaluates the prevalence, clinical patterns and outcomes of CNS involvement in a cohort of patients with primary Sjögren syndrome. We evaluated 93 patients with pSS diagnosed according to American-European Consensus Group criteria. Fourteen patients (15.1 %) had CNS involvement. All were women with an average age of onset of the disease of 42.1 ± 14.7 years (average ± SD) and an average age of onset of neurological involvement of 47.29 ± 16 years. Three had parkinsonian syndrome, two epilepsy, two motor and sensory deficits, two headache with brain magnetic resonance abnormalities, two neuromyelitis optica, two chronic progressive myelitis and one aseptic meningitis. Neurological involvement preceded Sjögren syndrome diagnosis in nine of the patients (64 %), and neurological outcome was good in 11 patients (78.6 %). Central nervous involvement was not as rare as expected, and the frequency was similar to the frequency of peripheral nervous system involvement. In half of the patients, this was the first symptom of the disease, emphasizing the importance of considering this diagnosis, especially in young female with neurological symptoms without other evident cause.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056402     DOI: 10.1007/s00296-014-3097-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.

Authors:  Mario García-Carrasco; Manuel Ramos-Casals; José Rosas; Lucio Pallarés; Jaime Calvo-Alen; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  Medicine (Baltimore)       Date:  2002-07       Impact factor: 1.889

3.  Central nervous system involvement in Sjögren's syndrome: unusual, but not unremarkable--clinical, serological characteristics and outcomes in a large cohort of Italian patients.

Authors:  Alfonso Massara; Sara Bonazza; Gabriella Castellino; Luisa Caniatti; Francesco Trotta; Massimo Borrelli; Luciano Feggi; Marcello Govoni
Journal:  Rheumatology (Oxford)       Date:  2010-05-05       Impact factor: 7.580

Review 4.  B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.

Authors:  Marinos C Dalakas
Journal:  Pharmacol Ther       Date:  2006-04-27       Impact factor: 12.310

Review 5.  Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature.

Authors:  R H Walker; H Spiera; M F Brin; C W Olanow
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

6.  Clinical manifestations of neurological involvement in primary Sjögren’s syndrome.

Authors:  Takahisa Gono; Yasushi Kawaguchi; Yasuhiro Katsumata; Kae Takagi; Akiko Tochimoto; Sayumi Baba; Yuko Okamoto; Yuko Ota; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2011-04       Impact factor: 2.980

7.  [Primary Sjögren's syndrome: exocrine and non-exocrine manifestations].

Authors:  Maria da Graça Henriques da Conceição Negrão Sequeira Muñoz; Walter Carlos Baptista Castelão; Fernando Manuel Diamantino Saraiva; José Carlos Teixeira da Costa; Mário Fernando Oliveira Viana de Queiroz
Journal:  Rev Bras Reumatol       Date:  2004-04

8.  [Primary Sjogren's syndrome: clinical and serological feature of a single centre].

Authors:  C Baldini; A Tavoni; G Merlini; M Sebastiani; S Bombardieri
Journal:  Reumatismo       Date:  2005-12

Review 9.  The geoepidemiology of Sjögren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

10.  Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Authors:  Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

View more
  21 in total

1.  Bilateral Internuclear Ophthalmoplegia as a Presenting Manifestation of Primary Sjögren's Syndrome.

Authors:  K S Natsis; E Boura; O Kyriazis; A Iliadis; S-A Syntila; I Kostopoulos; T Afrantou
Journal:  Neuroophthalmology       Date:  2016-09-07

Review 2.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

Review 3.  Multiple Sclerosis: Diagnosis and Differential Diagnosis.

Authors:  Sami Ömerhoca; Sinem Yazici Akkaş; Nilüfer Kale İçen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

4.  Primary Sjögren's syndrome (pSS)-related cerebellar ataxia: a systematic review and meta-analysis.

Authors:  Andreas Liampas; Antonios Nteveros; Konstantinos Parperis; Mohammed Akil; Efthymios Dardiotis; Elizabeth Andreadou; Marios Hadjivassiliou; Panagiotis Zis
Journal:  Acta Neurol Belg       Date:  2021-10-05       Impact factor: 2.396

5.  Cerebellar involvement in patients withprimary Sjögren's syndrome: diagnosis and treatment.

Authors:  Huaxia Yang; Yinghao Sun; Lidan Zhao; Xuan Zhang; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2018-01-29       Impact factor: 2.980

6.  Neurological Complications of Sjögren's Syndrome: Diagnosis and Management.

Authors:  Sara S McCoy; Alan N Baer
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-10-24

7.  Hypertrophic Pachymeningitis in Sjögren's Syndrome.

Authors:  Yumiko Nakano; Masayoshi Yamamoto; Kenichi Komatsu; Masato Yagita; Masaaki Fujita
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

8.  Clinical features and risk factors of neurological involvement in Sjögren's syndrome.

Authors:  Wenjing Ye; Siyan Chen; Xinshi Huang; Wei Qin; Ting Zhang; Xiaofang Zhu; Xiaochun Zhu; Chongxiang Lin; Xiaobing Wang
Journal:  BMC Neurosci       Date:  2018-04-27       Impact factor: 3.288

9.  Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome.

Authors:  Alexandria Voigt; Sukesh Sukumaran; Cuong Q Nguyen
Journal:  Rheumatology (Sunnyvale)       Date:  2014

10.  Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.

Authors:  Guillermo Carvajal Alegria; Dewi Guellec; Xavier Mariette; Jacques-Eric Gottenberg; Emmanuelle Dernis; Jean-Jacques Dubost; Anne-Priscille Trouvin; Eric Hachulla; Claire Larroche; Veronique Le Guern; Divi Cornec; Valérie Devauchelle-Pensec; Alain Saraux
Journal:  RMD Open       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.